Moorfields Eye Hospital
Moorfields Eye Hospital
London, United Kingdom6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Parasitic Ulcer Treatment Trial | Acanthamoeba keratitis, Infections, amebiasis, corneal disorder, corneal ulcer, eye disorder, eye infectious disorder, keratitis, parasitic eye infection, parasitic infectious disease, protozoa infectious disease | Recruiting | Phase 3 | 2026-10-01 | NCT06213649 | |
| Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns | Severe Diabetic Macular Oedema | Recruiting | Phase 3 | 2026-09-28 | NCT06985706 | |
| Rate of Progression in USH2A-related Retinal Degeneration | Usher syndrome type 2A, retinitis pigmentosa 39 | Active, not recruiting | Not stated | 2026-07-23 | NCT03146078 | |
| EyeConic: Qualification for Cone-Optogenetics | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder | Recruiting | Not stated | 2025-07-31 | NCT05294978 | |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deaf-Blind Disorders, Deafness, Ear Diseases, Eye Diseases, Hereditary, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Usher syndrome, Usher syndrome type 1B, blindness (disorder), eye disorder, hearing disorder, hearing loss disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, otorhinolaryngologic disease, retinal degeneration, retinal disorder, retinitis pigmentosa, vision disorder | Recruiting | Phase 1 / Phase 2 | 2025-05-02 | NCT06591793 | |
| Development of Novel Clinical Endpoints in Intermediate AMD | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Not stated | 2025-01-16 | NCT03349801 |